#USA #Veeva Systems #Life Sciences #Pleasanton #Ostro

Veeva’s Strategic Acquisition of Ostro

In a significant move, Veeva Systems (NYSE: VEEV) has recently announced its acquisition of Ostro, a leading brand engagement platform tailored for the life sciences sector. This strategic acquisition, valued at approximately $100 million in cash and long-term stock options, signifies a noteworthy shift in how information is conveyed between patients and healthcare professionals.

Enhancing Patient-Provider Interactions

Ostro stands out due to its advanced technology that employs a user-friendly, AI-powered chat experience. This innovation allows patients and doctors to receive immediate, compliant answers to their queries, effectively streamlining the communication process in a field where accurate information is crucial. Patients can visit Ostro-operated brand websites, where they can effortlessly ask questions and receive validated responses, resources, and recommendations for further steps in real-time.

The platform employs a sophisticated mix of conversational AI, semantic search, and industry-specific regulations to provide answers that undergo the Medical, Legal, and Regulatory (MLR) approval process. Unlike many competitive AI solutions, Ostro does not generate unpredictable or inaccurate responses, ensuring reliability and legal compliance in all interactions.

Veeva’s Vision for the Future

According to Peter Gassner, CEO of Veeva, the acquisition of Ostro aligns with a fundamental shift in how people access information today. He emphasized that the focus is no longer on the abundance of information but rather on the accessibility and ease with which customers can find answers. Gassner noted, “Ostro is at the forefront of assisting brands in ensuring that patients and healthcare providers have immediate access to correct information. We are excited to welcome Ostro to the Veeva team, where we will shape the future of AI-led customer engagement.”

Chase Feiger, the CEO of Ostro, shared the company's goal of reducing the time it takes to diagnose and treat ailments, underscoring that brand content should be easily retrievable while remaining compliant with legal standards. He expressed his enthusiasm about working with Veeva to expand Ostro’s reach, thereby providing more patients and providers with trustworthy answers while minimizing effort and confusion.

Future Integration Plans

As an independent business unit, Ostro will continue to operate under the leadership of Chase Feiger. Over time, Veeva and Ostro plan to integrate their platforms, enhancing the synergy between Ostro’s capabilities and Veeva's Commercial Cloud applications. This integration aims to enable seamless workflows that connect online and in-person engagements, ultimately fostering greater customer-centric approaches in the healthcare marketplace.

About Veeva Systems

Veeva is the industry's leading cloud provider for life sciences, offering software, data, and consulting services tailored to meet the sector's needs. The company prides itself on innovation, product excellence, and ensuring client success, servicing over 1,500 clients ranging from the largest biopharmaceutical companies to emerging biotech firms. Operating as a Public Benefit Corporation, Veeva aspires to align the interests of all its stakeholders, including customers, employees, shareholders, and the various industries it influences.

For more detailed insights about their offerings, visit veeva.com.

Looking Ahead

Veeva’s acquisition of Ostro not only reinforces its commitment to advancing healthcare communication but also represents an exciting evolution in the landscape of patient engagement technologies. As both companies embark on this journey together, the potential for enhancing the patient care experience seems boundless, promising a future where healthcare information is more accessible and reliable than ever before.

For further information, visit ostro.veeva.com.